Thursday, April 20, 2017

Hundreds of #Marijuana #Investors Meet Dozens of Start Ups in Austin, TX May 2-3

Hundreds of #Marijuana #Investors Meet Dozens of Start Ups in Austin, TX May 2-3

Noted Canadian entrepreneur Jim Estill and Austin-based herbal products pioneer Mark Blumenthal to address the group; Dozens of Promising Cannabis Companies from Around the World Pitch Investors in 'Shark-Tank' Style Format


Austin, TX - April 20, 2017 (Investorideas.com Newswire) More than 200 high-net worth investors from around the world, eager to invest in the fastest growing industry in America will gather at AT&T Conference & Education Center for a two day "Shark Tank"-like pitch forum on Tuesday, May 2nd and Wednesday, May 3rd, hosted exclusively for members of The Arcview Investor Network. A disproportionate number of Arcview's most active investors reside in Texas and have an opportunity to learn of promising companies in one the fastest growing entrepreneurial cities in the country.
Arcview is the top source of deal flow for the cannabis industry. It's members have placed $112M into 141 cannabis-related companies.
Jim Estill, Canadian entrepreneur, investor and CEO of Danby Appliances, and Mark Blumenthal, founder of the American Botanical Council, will deliver keynote speeches. Accredited investors will be reviewing pitches from more than a dozen companies who competed fiercely for the pitch slots out of a field of hundreds of applicants.
Texas has already passed a law allowing non psychoactive cannabidiol (CBD) for residents and will soon consider whether to legalize medical cannabis use.
  • Who: Members of The Arcview Investor Network plus cannabis-related companies chosen to present
  • What: Select media representatives will be invited to witness presentations from companies that have been successful at raising capital from this group and those who are hoping to attract investors at this meeting. Throughout the day, select reporters will be able to interview high net worth investors who have recently invested in the sector or are considering it, companies that have recently been funded, and elected officials that support legalization.
  • When: Tuesday, May 2nd and Wednesday, May 3rd between 9:30AM – 4:00PM
  • Where: AT&T Conference Center, 1900 University Avenue, Austin, TX 78705
  • How: Members of the media must apply for press credentials by emailing abbybenjamin@arcviewgroup.com
Learn more about the growth of the cannabis industry via this short video. To get a sense of what to expect at Arcview, see this other short video.
About The Arcview Group
Founded in 2010, The Arcview Group is responsible for a number of groundbreaking ventures in the cannabis industry. The Arcview Investor Network includes more than 625 accredited investors who have put more than $112 million behind 141 companies. Arcview Market Research publishes the State of Legal Marijuana Markets report, which is the most oft-cited market data report. In 2015 Arcview became a partner in Canopy, the first seed-stage mentor-driven business accelerator. Arcview is also co-founder of Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry.
Contact:
Abby Benjamin, Media Relations
abbybenjamin@arcviewgroup.com
720-518-7611

Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Montel Williams Debuts Line of Medical Cannabis Products

Montel Williams Debuts Line of Medical Cannabis Products

San Francisco, CA - April 20, 2017 (Investorideas.com Newswire) On Tuesday April 18, 2017, Lenitiv Scientific LLC debuts its line of high-quality medical cannabis products for patients, under the brand name LenitivLabs, in dispensaries across California. Alongside the debut, media personality Montel Williams, founder of Lenitiv Scientific, will host the following launch events at Bay Area dispensaries:
  • April 18, 7pm to 9pm, at Caliva (1695 S 7th St, San Jose, CA 95112)
  • April 19, 7pm to 9pm, at Purple Lotus Patient Center (752 Commercial St #20, San Jose, CA 95112)
  • April 21, 7pm to 9pm, at Harvest on Geary (4811 Geary Blvd, San Francisco, CA 94118)
LenitivLabs' line of proprietary products utilize the latest cannabis manufacturing technologies and research to deliver the highest quality and consistency to patients. The line includes cannabis oils that patients can conveniently load into vaporizers as well as a cannabis infused drink. Patients will feel safe knowing there are no harmful additives and the products are clearly labeled and packaged in consistent, standardized doses.

"I'm thrilled to be debuting LenitivLabs," says founder Montel Williams. "My mission—and the mission of our entire Lenitiv team—is to ensure that patients like myself have access to the highest-quality medicine available."
Williams—an award-winning media personality, decorated former Naval officer, entrepreneur, and wellness advocate—was diagnosed with Multiple Sclerosis (MS) in 1999 and has used cannabis products as a medication to manage the disease's symptoms.
"Medical cannabis has allowed me to live a productive, fruitful life despite having multiple sclerosis," says Williams. "Many thousands of others across this country have experienced the same thing, which is what drove me to launch Lenitiv Scientific."
Williams is one of the nation's highest-profile advocates for cannabis law reform and has championed the cause for the past seventeen years. He has worked to pass medical cannabis legislation in states such as Pennsylvania, New York, Ohio, New Jersey, and Connecticut and continues to advocate for reform at the federal level and in states where medical cannabis laws are not currently in effect. An outspoken advocate for America's servicemen and women, Williams has led the push for military veterans to legally access medical cannabis without the threat of losing benefits.
Beginning in April, LenitivLabs' product line will be available for patients with a doctor's recommendation at dispensaries throughout northern and southern California (for a full list of dispensaries that carry LenitivLabs, please visit the LenitivLabs website) with plans to expand to other states that allow for the sale of medical cannabis.
Note: Lenitiv Labs, LLC operates in California as a non-profit mutual benefit corporation. All products are manufactured in a licensed facility in strict compliance with local and state laws. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease.
About Lenitiv Scientific
Lenitiv Scientific develops innovative, high quality medical cannabis products for patients. The company works closely with regulators and provides education for the broader community on topics such as proper dosage and methods of delivery. Lenitiv Scientific was founded by Montel Williams and former pharmaceutical executive David Racz, who serves as CEO. The company's world class advisory board includes Former Director, Central Intelligence, Ambassador R. James Woolsey; Retired Vice Admiral Edward M. Straw; former Congressman Wilbert Tauzin, former owner of General Drug, Basil Falcone; Lindy Snider; and Nancye Miller-Woolsey.
SOURCE LenitivLabs
Related Links: http://lenitivlabs.com


Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Wednesday, April 19, 2017

WeedMD Inc. (TSX VENTURE: $AMN.P) Announces Closing of Qualifying Transaction

WeedMD Inc. (TSX VENTURE: $AMN.P) Announces Closing of Qualifying Transaction


TORONTO, ONTARIO - April 19, 2017 (Investorideas.com Newswire) WeedMD Inc. (TSX VENTURE:AMN.P) (formerly Aumento Capital V Corporation ("ACC")) (the "Company"), is pleased to announce that it has closed its previously announced business combination (the "Transaction") with WeedMD Rx Inc. ("RX"). The Transaction consisted of the acquisition by the Company of all of the issued and outstanding securities in the capital of RX by way of a three-cornered amalgamation, pursuant to which a wholly-owned subsidiary of the Company amalgamated with RX.
Pursuant to the Transaction, each RX shareholder received 1.25 common shares in the capital of the Company for each RX common share held, resulting in the issuance of an aggregate of 58,577,376 common shares of the Company to shareholders of RX. As part of the Transaction, warrants, compensation options and stock options of RX were replaced with common share purchase warrants, compensation options and stock options of the Company with adjustments to their exercise or conversion terms to reflect the exchange ratio for the RX common shares under the Transaction, resulting in the issuance of: (i) common share purchase warrants exercisable to purchase up to 14,888,486 common shares at an exercise price of $0.80 per share; (ii) stock options exercisable to purchase up to 3,312,500 common shares at an exercise price of $0.60 per share; and (iii) 440,000 compensation options exercisable into units at an exercise price of $0.60 per unit, with each unit comprised of a common share and one-half of one warrant, with each whole warrant exercisable into a common share at an exercise price of $0.80.
As part of the Transaction, the Company changed its name from "Aumento Capital V Corporation" to "WeedMD Inc.".
As a result of the Transaction, RX is now a wholly-owned subsidiary of the Company, and the Company will continue the business of RX which is licensed under the Access to Cannabis for Medical Purposes Regulations to cultivate marijuana seeds and plants and dried marijuana product from its facilities located in Aylmer, Ontario. RX has applied for an amendment to its ACMPR license to allow for the sale of plants/dried materials (the "Sales License"). RX has completed the review and inspection process with Health Canada with respect to the Sales License. Upon RX satisfying any further documentary or other requests of Health Canada, WeedMD expects to receive its Sales License in the second quarter of 2017. There are no mandated timelines in the ACMPR for the license review process.
Prior to the Transaction, ACC was a Capital Pool Company (as defined under the policies of the TSX Venture Exchange (the "Exchange")), and had not commenced commercial operations and had no assets other than cash. The Transaction constituted ACC's "Qualifying Transaction", as such term is defined in Policy 2.4 of the Exchange.
Final acceptance of the Transaction will occur upon the issuance of a Final Exchange Bulletin by the Exchange. Upon issuance of the Final Exchange Bulletin, the Company will cease to be a Capital Pool Company and will recommence trading on the Exchange as a Tier 1 life sciences issuer. Trading in the common shares of the Company will begin on the Exchange on April 27, 2017 under the symbol "WMD".
Following the completion of the Transaction (on a post-acquisition basis), the Company has a total of 60,517,058 common shares outstanding, as well as: (i) common share purchase warrants exercisable to purchase up to 14,888,486 common shares at an exercise price of $0.80 per share; (ii) stock options exercisable to purchase up to 3,497,332 common shares at an exercise price of $0.60 per share; (iii) 440,000 compensation options exercisable into units at an exercise price of $0.60 per unit, with each unit comprised of a common share and one-half of one warrant, with each whole warrant exercisable into a common share at an exercise price of $0.80; and (iv) 1,125,000 common shares issuable to certain officers of the Company upon RX receiving the Sales License (the "Compensation Shares").
An aggregate of 23,388,441 common shares are subject to escrow pursuant to Exchange escrow requirements (not including the Compensation Shares which will also become subject to escrow upon issuance).
As a result of the closing of the Transaction, the directors and executive officers of the Company are now:
Michael Kraft Chairman
Bruce Dawson-Scully Chief Executive Officer and Director
Keith Merker Chief Financial Officer and Director
Luc Duchesne Chief Scientific Officer
Gail Paech Director
David Danziger Director
Rick Moscone Director
Further details about the Transaction and the Company as the resulting issuer from the Transaction are available in the filing statement of ACC dated March 31, 2017 filed in respect of the Transaction which has been filed under ACC's profile on SEDAR at www.sedar.com. The summary of the Transaction set out herein is qualified in its entirety by reference to the description of the Transaction in the filing statement.
Forward-Looking Information
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Company's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information
Keith Merker
Chief Financial Officer
WeedMD Inc.
519-765-2440 Ext. 222

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks




Watch the 420 Cannabis Investor video

 

More Info:



This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Canadian Cannabis Stock News: Lotus Ventures Inc (CNSX: $J) Cannabis Facility Permits Issued

Canadian Cannabis Stock News: Lotus Ventures Inc (CNSX: $J) Cannabis Facility Permits Issued


VANCOUVER, BC - April 19, 2017 (Investorideas.com Newswire) Lotus Ventures Inc. (CNSX: J) is pleased to report that its activities to obtain Licensed Producer (LP) status under the Health Canada, Access To Cannabis For Medical Purposes Regulations (ACMPR) has moved forward and we are poised to begin construction of the first facility in 2017.
Lotus has received approval for the necessary building permit for its proto-type facility from Spallumcheen Township near Armstrong BC. We have received a binding financial commitment to fund the two-stage construction, previously announced on January 30, 2017 and have received further information that Lotus Ventures Inc. has well advanced along in the approval process and expects to receive an affirmation confirmation from Health Canada to commence building this year. We have also created a community contribution profile which highlights our creation of 60 - 70 permanent jobs from the initial $18 million investment plan in the North Okanagan region.
Health Canada has increased its budget and staffing, which will increase the speed at which it issues affirmation confirmations and processes LP applications. The Federal Government has issued legislation in favor of LP's being the permitted producers in the adult recreation legal market to commence July 1, 2018.
These announcements are material milestones for Lotus Ventures becoming an important market participant in the rapidly-developing Canadian regulated market for both medical and adult recreational use markets. We anticipate events developing more rapidly, in the near future, and will keep our shareholders informed as we move forward with our business plans.
ON BEHALF OF THE BOARD
Lotus Ventures Inc.
Dale McClanaghan, President and CEO
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
For further information, contact:
Dale McClanaghan
President and CEO
(604) 644-9844


Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks




Watch the 420 Cannabis Investor video

 

More Info:



This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

#Cannabis Stock News Just in Time for 4/20; SinglePoint Inc. (OTC: $SING) Added to #420CannabisInvestorIdeas Directory

#Cannabis Stock News Just in Time for 4/20; SinglePoint Inc. (OTC: $SING) Added to #420CannabisInvestorIdeas Directory




April 19, 2017 (Investorideas.com Newswire) Cannabis stock news for 4/20 - www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, and its affiliated directory www.420cannabisinvestorideas.com announce the most recent addition to the 420 Cannabis Investor Ideas of 2017; SinglePoint Inc. (OTC:SING), an acquisition based company focused in the cannabis space. Most recently SinglePoint acquired a stake in Convectium, a profitable company supplying hardware solutions to the cannabis industry.
The 420 Cannabis Investor Ideas of 2017 will feature a maximum of 420 companies to be showcased for a year. Investorideas.com will create a free downloadable PDF of the full directory for investors to use as a reference and due diligence tool.
SinglePoint's(OTC: SING) flagship product is a best-in-class mobile commerce and communications platform that enables dispensaries to market to consumers through SMS messaging and accept electronic payments. By building a network of dispensaries leveraging its SMS marketing technology, the company is positioning itself to take advantage of a vast opportunity in the payments space when federal guidelines surrounding cannabis banking are finalized. The company is focused on providing business solutions to the enterprises rather than cultivation and consumers. In a market that is so heavily regulated by the government SinglePoint's hands-off approach offers investors an opportunity to diversify their portfolio.
SinglePoint (OTC: SING) recently revamped their corporate website, aimed at providing investors easier access and transparency to the company's initiatives. While this site will be corporate focused, SinglePoint will continue to offer solutions to the cannabis industry through its subsidiary SingleSeed.com.
New Frontier Data (also featured on the 420 Cannabis Investor Ideas Directory), the authority in business intelligence for the cannabis industry, forecasts the legal cannabis market to grow to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 16%.
Their Cannabis Industry Annual Report "2017 Legal Marijuana Outlook", also found that if all the states which are currently legal continue their projected growth, they could generate $2.3 billion in state tax revenue from retail sales by 2020 and the U.S. Cannabis Market will Create 283,422 Jobs by 2020.
With all this money at stake its growth opportunity has been compared to the beginnings of the internet. But with all the opportunity comes the risk as well. The directory is meant to be one of several tools investors can use as a go-to resource to navigate the sector. 
See more info and additional 420 listings on www.420cannabisinvestorideas.com
Learn more about how to submit your company: http://www.investorideas.com/420cannabisinvestorideas/
Watch 420 Cannabis Investor Ideas Video: https://www.youtube.com/watch?v=e2zFezO580Y
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.
Contact Investorideas.com
800-665-0411